Primate BC200 RNA is a 200~nucleotide-long, nontranslatable RNA that is prevalently expressed in the nervous system. We have determined the primary structure of human BC200 RNA, using cDNA cloning and PCR techniques. BC200 RNA can be subdivided into three structural domains. The 5' region is homologous to Alu repetitive elements that are found in high copy numbers in primate genomes. The central part of BC200 RNA is characterized by a high percentage of A-residues, with a few interspersed other nucleotides. The 3' sequence is unique to BC200 RNA and shows no apparent similarity with known human DNA sequences.
Sequence similarity with rodent BCl RNA is limited to several short elements, and BCl /BC200 sequence comparisons indicate that the two genes have evolved via separate phylogenetic routes. Probes directed against the 3' unique part of BC200 RNA detected a single band corresponding to approximately 200 nucleotides on RNA blots. This band was identified only with RNA isolated from human brain, not with RNA from nonneural organs such as lung or kidney. In situ hybridization to selected areas of the human nervous system showed that BC200 RNA is expressed by a subpopulation of neurons that is analogous to the BCl RNA-expressing subset of neurons in the corresponding areas of the rat nervous system. Moreover, like rat BCl RNA, human BC200 RNA was localized to dendrite-rich neuropil areas, for example, in the inner plexiform layer of the retina. These results indicate that BCl RNA and BC200 RNA, although of different evolutionary pedigree, may play analogous functional roles, in rodents and primates, respectively, in somatodendritic domains of nerve cells.
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The concept of localized protein synthesis in dendrites has received increasing experimental support in the past years (see Steward and Banker, 1992 , for review). Thus, it has been shown that polyribosomes are located beneath synaptic sites, in par-titular at the base of dendritic spines, in dentate granule cells of the hippocampus (Steward and Levy, 1982; Steward and Reeves, 1988) . Dendritic polyribosomes are particularly prominent during periods of developmental and reactive synaptogenesis (Steward, 1983; Steward and Falk, 1986) . The accumulation of polyribosomes within dendritic spines of the visual cortex has been shown to be substantially higher in rats reared in complex environments than in control littermates (Greenough et al., 1985) . Furthermore, it has been demonstrated that RNA is actively transported into dendrites but not into axons of hippocampal neurons in culture (Davis et al., 1987 (Davis et al., , 1990 .
The mRNAs for a limited number of dendritic proteins have been detected in dendrites at significant levels. One of them codes for the high-molecular-mass form of microtubule-associated protein MAP2 (Garner et al., 1988; Papandrikopoulou et al., 1989; Tucker et al., 1989; Bruckenstein et al., 1990; Kleiman et al., 1990) , another one for the a-subunit of Ca*+/calmodulin-dependent protein kinase type II (CaM-KII) (Burgin et al., 1990; Benson et al., 1991) . High-molecular-mass MAP2 is a tubulin-binding protein specifically associated with the dendritic cytoskeleton (see Cleveland, 1990 , for a review). CaM-KII is highly enriched in postsynaptic densities and may be involved in signal transduction mechanisms and in the induction of long-term potentiation (for a review, see Kennedy, 1989) . Furthermore, the mRNA for the amyloid precursor protein (APP) has been detected in proximal dendritic domains of developing hippocampal neurons in culture (Strong et al., 1990) , and recently, the mRNA encoding brain-derived neurotrophic factor (BDNF) has been identified in proximal dendritic segments of dentate granule cells during postnatal development (DugichDjordjevic et al., 1992) .
Dendritic mRNAs have been detected in hippocampal synaptosome preparations (also referred to as "synaptodendrosomes") that had been enriched in dendritic spine material (Chicure1 et al., 199 1) . Active protein biosynthesis has recently been demonstrated in preparations of synaptosomes (Rao and Steward, 199 1) as well as in preparations of dendrites that had been physically isolated from hippocampal neurons in culture (Torre and Steward, 1992) . These data provide important support for the hypothesis that nerve cells are capable of synthesizing selected dendritic proteins locally, close to the respective postsynaptic sites where they are required. Such a mechanism may enable neurons to regulate dendritic protein repertoires in situ, for example, in response to local synaptic stimuli.
Rat BC 1 RNA is a short RNA polymerase III transcript that is almost exclusively expressed in nerve cells (DeChiara and Brosius, 1987; McKinnon et al., 1987; Tiedge et al., 1991) . BCl RNA has been detected in a subset of neurons where it is located in somatic and/or dendritic domains, and its dendritic location has been suggested to indicate a functional role in postsynaptic compartments of neurons, conceivably in the context of local translation-related processes (Tiedge et al., 199 1) . Recent data (Kobayashi et al., 1991 (Kobayashi et al., , 1992 Cheng et al., 1992) suggesting that BCl RNA is likely to be complexed with proteins to form a ribonucleoprotein particle (RNP) would be consistent with such a notion. It has also been shown recently that BCl RNA is a prominent component of isolated dendritic spines (M. Chicurel, D. M. Terrian, and H. Potter, personal communication) and synaptodendrosomes (A. Rao and 0. Steward, personal communication) , where it is colocalized with dendritic mRNAs. This colocalization is further evidence to support a role of BC 1 RNA in synapse-associated protein synthesis.
While a direct BCl homolog has not been described in primates, a partial cDNA sequence from monkey BC200 RNA, also a brain-specific RNA polymerase III transcript, has been reported earlier (Watson and Sutcliffe, 1987) . However, because of the extensive homology of this sequence with the highly repetitive Alu elements, probes that would specifically identify BC200 RNA were not available, and as a result, the expression of this RNA in the human nervous system and its subcellular distribution could not be assessed. Here we report the sequence, including the unique (non-Alu) 3' part, of human BC200 RNA. Using probes against the unique part of BC200 RNA, we describe its distribution in human neural tissue. Although of limited sequence similarity with its rat counterpart BCl RNA, human BC200 RNA exhibits a strikingly similar expression pattern in selected parts of the human nervous system. In addition, we show that BC200 RNA, comparable again to rat BC 1 RNA, is associated with both somatic and dendritic domains of various types of neurons. These data indicate that both RNAs, although presumably of separate phylogenetic background, may perform analogous functional roles in postsynaptic domains of nerve cells.
Materials and Methods
Cloning of human BCZOO RNA. Total cellular RNA and polyA+ RNA were isolated from human neocortex according to the method of Feramisco et al. (1982) . Five micrograms of polyA+ RNA were tailed with CTP, using polyA polymerase, and the C-tailed RNA was converted into double-stranded cDNA as previously described (DeChiara and Brosius, 1987) . EcoRI-adaptors (Pharmacia) were attached, according to the instructions of the manufacturer, and cDNA smaller than about 400 base pairs was selected on a 4% polyacrylamide gel. Electra-eluted cDNA was cloned into ZAP (Stratagene), following the manufacturer's manual. We screened 3.6 x lo4 plaques with an oligonucleotide probe complementary to the sixty 3'-most nucleotides of rat BCl RNA (DeChiara and Brosius, 1987; Tiedge et al., 1991) at low stringency (final wash at 35°C in 6 x SSC; 1 x SSC is 150 mM sodium chloride, 15 mM sodium citrate, pH 7.4). Four clones were identified as positive, and the sequences of their inserts (both strands) were determined using the enzymatic chain termination reaction (Sanger et al., 1977; Toneguzzo et al., 1988) . Twelve additional clones were later identified and sequenced after rescreening of the library with oligonucleotide probes complementary to specific BC200 RNA sequences (see below).
PCR amplijication of 5' and 3' domains of BC200 RNA. For amplification of the 5' BC200 sequence, 1 pg total RNA from human neocortex was converted into first-strand cDNA using the thermostable rTth DNA polymerase (Perkin Elmer Cetus) according to the instructions of the manufacturer. The primer used in this step was 5'-GTTGTTGCTTTGAGGGAAG-3' (WC00 1). The 3' end ofthe product was then T-tailed using dTTP and terminal transferase (Boehringer Mannheim). The tailedcDNA was PCR amplified (Frohman et al., 1988) in 30 cycles (denaturation for 30 set at 94°C annealing for 1 min at 55°C extension for 2 min at 72°C; initial denaturation was for 4 min at 94°C final extension was for 10 min at 72"(Z), using the primers 5'-GCCTTCGAATTCAGCACCGAGGGAAGTTACGCTTA-3'
(WC-004), and 5'-GCCTTCGAATTCAGCACCAAAAAAAAAAAAA-AAAA-3' (HT021). The products were further amplified in a second set of 30 cycles (for conditions, see above), using the adapter primer 5'-GCCTTCGAATTCAGCACC-3' (HT023). After digestion with EcoRI, the PCR products were cloned into the EcoRI site ofZAP (Stratagene) following the manual of the manufacturer; lo3 plaques were screened with an internal oligonucleotide probe 5'-AAAAAAAAA(T/A)(T/ G)GCCGGGCGCGGT-3' (WCOO7), and six positive clones were sequenced.
For amplification of the 3' BC200 sequence, 10 pg total RNA from human neocortex was A-tailed using polyA polymerase (DeChiara and Brosius, 1987) . Tailed RNA was then converted into first-strand cDNA with reverse transcriptase in the presence of MeHgOH (Invitrogen), using the primer 5'-GCCTTCGAATTCAGCACCTTTTTTTTT-TTTTTTTT-3' (HT022). This primer, in combination with the primer 5 -GCCTTCGAATTCAGCACCAAAATAAGCGTAACTTCCC-3' (WCOOS), was also used for PCR amplification (see above). Products were cloned into ZAP11 (see above), and 14 clones that were identified with WC005 were sequenced using the enzymatic chain termination reaction.
DNA and RNA blots. Human genomic DNA was prepared from human blood (Smith et al., 1988) . Southern analysis ofgenomic DNA was performed as described by Devlin et al. (1988) . The oligonucleotide probe was complementary to the sequence 5'-AAATAAGCGT-AACTTCCCTCAAAGCA. in the 3' unique domain of BC200 RNA. and the final wash was done at 70°C (high strinaencv) or at 56°C (low stringency). For RNA blots, 10 pg of total cell& RNA was run per lane on a 1.5% agarose gel containing 2% formaldehyde (Sambrook et al., 1989) . The RNA was transferred onto GeneScreen membranes (New England Nuclear) and immobilized by UV illumination (Church and Gilbert, 1984) . The oligonucleotide probe used for detection of BC200 RNA on RNA blots was complementary to the 3' unique BC200 sequence 5'-ATAAGCGTAACTTCCCTCAAA-3'.
The BCl oligonucleotide probe was complementary to the sixty 3'-most nucleotides of BCl RNA (see above). Hybridization was performed as described by Sambrook et al. (1989) , and the final wash was in 2 x SSC at 30°C.
In situ hybridization. Human tissue (postmortem intervals ~6 hr) was formaldehyde-fixed and equilibrated in a series of ascending sucrose concentrations as described (Hof and Morrison, 1990) . The tissue was then cryo-embedded, sectioned at 10 pm thickness at -2o"C, and stored at -80°C until use.
Probes used to detect human BC200 RNA in in situ hybridization experiments were equivalent to the oligonucleotide probe used for DNA blots and corresponded to the sequence 5'-AAATAAGCGT-AACTTCCCTCAAAGCAACAA-3' in the 3' unique domain. A transcription vector (pVL 450-l) containing this sequence was constructed by inserting a chemically synthesized piece of DNA with the appropriate restriction site termini between the KpnI and the Sac1 sites ofpBluescript KS( +) (Stratagene). A transcription vector for generating probes specific for GAP-43 mRNA has been described earlier (Neve et al., 1988) . ?Slabeled RNA probes were transcribed from linearized templates, using SP6 (GAP-43 mRNA "antisense"), T3 (BC200 RNA "sense"), and T7 RNA polymerase (BC200 RNA "antisense", GAP-43 mRNA "sense") as recommended by the manufacturers (Promega and Bethesda Research Labs).
In situ hybridization was performed as described (Tiedge, 199 1) . The final high-stringency wash was in 0.1 x SSC, 0.05% sodium pyrophosphate, 14 mM 2-mercaptoethanol, at 37°C (BCZOO RNA) or 50°C (GAP-43 mRNA), respectively. Posthybridization treatments, emulsion autoradiography, and microphotography have been described earlier (Fremeau et al., 1989; Tiedge, 1991) .
Results
Cloning of human BC200 RNA The results of initial RNA blot experiments indicated that a probe complementary to the 3' unique part of rat BCl RNA identified a transcript of about 200 nucleotides in RNA isolated from human brain (Fig. 1A) . This transcript was detectable in total RNA and in polyA+ RNA, but not in polyA-RNA. We reasoned that the structure of the human transcript might be equivalent to rat BCl RNA in that an A-rich domain is centrally located in the RNA (DeChiara and Brosius, 1987) Figure 1 . RNA and DNA blot analysis of human BC200 RNA. A and B, RNA blot analysis. A, Ten micrograms of total RNA from rat brain (lane 1) and from human neocortex (lanes 2 and 3) were run on a 1.5% denaturing agarose gel. RNA loaded in lanes 2 and 3 was from two different preparations. The oligonucleotide probe was complementary to the sixty 3'-most nucleotides of rat BCl RNA. B, Ten micrograms of total RNA from human neocortex (lane I), from human lung (lanes 2 and 3), and from human kidney (lanes 4 and 5) were probed with an oligonucleotide complementary to the unique BC200 sequence. Duplicate samples correspond to different preparations. Equal loading was verified by visualization of ribosomal RNA under UV light (not shown). Arrowheads indicate the positions of 28s rRNA (upper arrowhead) and 18s rRNA (lower arrowhead). C and D, Southern analysis of genomic DNA. Forty micrograms of human genomic DNA were digested with PstI (P), Sac1 (3, PvuII (Pv), BamHI (E), EcoRV (I"), and EcoRI (R), respecuvely. Twenty micrograms of each digest were run on a 1% agarose gel, transferred to filters, and hybridized according to Devlin et al. (1988) . Duplicate filters were washed at 70°C (C) or at 56°C (D); X fragments, generated by Hind111 digestion of X DNA, were radiolabeled and loaded as size markers in lane M.
as in a typical mRNA. We therefore used polyA polymerase to add an oligoC tail to the 3' end of polyadenylated RNA from human brain, and we constructed a cDNA library after priming with oligo-dG, thereby avoiding unwanted priming in the center of the RNA. The cDNA library was subsequently screened with an oligonucleotide probe complementary to the sixty 3'-most nucleotides of rat BCl RNA.
The validity of this approach was confirmed by the sequence of human BC200 RNA (Fig. 2) . These data were obtained by sequence analysis of 16 overlapping clones, and no sequence discrepancies were observed among these clones except for the length of homopolymeric A-and C-tracts. The variable length of homopolymeric regions is most likely due to errors during cDNA synthesis (DeChiara and Brosius, 1987) , and Figure 2 gives the length of such tracts as derived from sequence analysis of a subsequently isolated genomic clone (J. A. Martignetti and J. Brosius, unpublished observations).
Like rat BCl RNA, human BC200 RNA can be subdivided into three major structural domains (Fig. 2) . The 5' part (120 nucleotides) shares homology with a previously published partial cDNA sequence from cynomolgus monkey BC200 RNA (Watson and Sutcliffe, 1987) , and it is furthermore homologous to the left monomer of Alu-J repetitive elements (Willard et al., 1987) and to free left Alu monomers (Jurka and Zuckerkandl, 1991; Quentin, 1992) in the human genome. The 5' domain contains consensus elements A and B of the split RNA polymerase III promoter (Galli et al., 198 l) , as well as two sequence elements that have recently been identified as the consensus motifs in signal recognition particle (SRP) RNA (see Walter and Blobel, 1982) for the binding of SRP heterodimeric protein 9/ 14 (boxes 1 and 2 of SRP9/14 binding site IIB; Strub et al., 199 1) . The 5' domain is followed by a central A-rich region, which in turn is followed by a stretch of 42 nucleotides at the 3' end of the RNA. This 3' sequence is unique to BC200 RNA: computer searches failed to detect any significant similarity with DNA sequences compiled in the GenBanWEMBL Data Bank. In addition, Southern analysis of genomic DNA revealed only two bands when a probe against the 3' part was used at high stringency (see below). The unusual C-tract in the 3' domain has also been detected in a genomic clone and is therefore unlikely to be the result of posttranscriptional modification.
Only two out of 16 cDNA clones showed 3'-terminal T-residues following the internal C-tract (see Fig. 2 and below) , and all of the clones varied with respect to their S-terminal sequence extent. Thus, in order to verify the extreme 5' and 3' sequences of BC200 RNA, we devised amplification schemes, based on PCR in combination with enzymatic tailing procedures. For the determination of the 5' sequence, RNA isolated from human brain was reverse transcribed, using oligonucleotide WC00 1 as a primer, and first-strand cDNA was tailed with dTTP, using terminal transferase. For the determination of the 3' sequence, brain RNA was tailed with ATP, using polyA polymerase, and then converted into first-strand cDNA by reverse transcriptase. The cDNAs were then amplified, cloned into a X vector, identified with internal oligonucleotide probes, and sequenced as described in Materials and Methods. All cDNA clones obtained in this way were colinear with corresponding parts of our original cDNA clones, obtained by library screening, and with corresponding parts of a subsequently isolated genomic clone. The 5' terminal sequence of BC200 RNA was determined from six independent clones, obtained by the PCR-based method (see Fig. 2) ; it is identical with the 5' sequence of cynomolgus BC200 RNA (Watson and Sutcliffe, 1987) , but falls one nucleotide short ofthe 5' end ofSRP RNA (Ullu et al., 1982) , and two nucleotides short of the 5: end of Alu elements (Jurka and Milosavljevic, 1991) . This result may be explained by (1) different transcriptional start sites in BC200 RNA versus SRP RNA, (2) differential posttranscriptional modification in vivo, or (3) inefficient reverse transcription of distal 5' nucleotides in vitro, prior to the tailing and amplification steps. At the 3' end of BC200 RNA, a stretch of maximally three T-residues was identified in PCR amplification products, thus confirming the sequence of the 3'- Figure 2 . Sequence of unmodified BC200 RNA as deduced from cDNA clones and PCR amplification products. Sixteen overlapping cDNA clones were analyzed. Overlapping sequences were identical except for length heterogeneity in the homopolymeric A-tracts in domain II and the homopolymeric C-tract in domain III. The length of the homopolymeric tracts shown here was based on sequence information from a genomic clone (Martignetti and Brosius, unpublished observations). The sequence of the genomic clone is 100% colinear with the human BC200 RNA sequence shown here. Nucleotide 7 was the Y-most nucleotide that was obtained through sequencing of cDNA clones. Nucleotides 3-6 were determined by sequence analysis of PCR-amplified BC200 domains (see Results). The sequence of nucleotides 1 and 2 (in italics) was adopted from a genomic clone and is identical to the published 5' sequence of Alu-J repetitive elements. Nucleotide 1 corresponds to the S-most nucleotide of Alu elements, and nucleotide 2 corresponds to the Y-terminal nucleotide of SRP RNA. The cDNA clone that extended 3'-most ended with three thymidine residues, followed by a stretch of cytidine residues that corresponds to the enzymatically added C-tail (not shown here). Clones obtained through tailing and PCR amplification also showed a maximum of three T-residues at the 3' end. The fact that most of the original cDNA clones showed no 3' T-residues is probably attributable to oligo-dG priming at the internal C-tract rather than at the enzymatically added C-tract. The consensus sequence of the split RNA polymerase III promoter (boxes A and B) is underlined, and elements corresponding to boxes 1 and 2 of SRP9/14 binding site IIB in SRP RNA are double overlined (see also Results). Sequences other than human BC200 RNA are given only insofar as they differ from that sequence. Dots denote sequence identity with human BC200 RNA, and dashes denote gaps that were introduced in order to increase similarity. Double slashes (//) demarcate the ends of available monkey BC200 sequence. Double arrows (< or W) indicate the ends of sequence similar&v of the left monomer of Alu-J or of rat BC 1 RNA. resnectivelv. with human BC200 RNA. The seauence of 103 nucleotides of BCl RNA that lies 3' to the sequence shown here contains a stretch that is homologous to the repetitive ID elements inihe rat genome (DeChiara and Brosius, 1987) . Space in brackets ([ ]) represents the central part of SRP RNA (187 nucleotides, positions 80-266) that is not homologous to the Alu-J left monomer. The last U residue given for SRP RNA is the 3' terminus. The SRP RNA sequence chosen here corresponds to the 7L30.1 locus that represents an authentic gene of human SRP RNA (Ullu and Weiner, 1984) . Lowercase letters were used when any of the additional available human subforms or other mammalian SRP RNAs (Zwieb and Nielsen, 1992) show identity with BC200 RNA in that position. hBC200 RNA, human BC200 RNA, mBC200 RNA, monkey BC200 RNA, rBCI RNA, rat BCl RNA. most extending cDNA clone (Fig. 2) . A genomic clone showed four T-residues at this position, a motif likely to represent a transcription termination signal for RNA polymerase III (Bogenhagen and Brown, 198 1). A partial cDNA sequence from cynomolgus monkey BC200 RNA has been reported earlier (Watson and Sutcliffe, 1987) . The monkey sequence is highly homologous to the 5' domain of human BC200 RNA as described in this article (see Fig. 2 ). In the previous report, however, no sequence information was available about the central A-rich domain or the 3' unique domain of BC200 RNA. Thus, because of the homology of the 5' part with Alu repetitive elements, suitable probes were lacking to identify specific BC200,sequences.
In the following, we use probes specific to the unique 3' part of BC200 RNA in order to probe neural and non-neural organs for the presence of BC200 RNA, to identify BC200 genes in genomic DNA blot analyses, and to localize BC200 RNA in human neural tissue.
We designed oligonucleotide probes complementary to parts of the unique 3' domain of human BC200 RNA (see Materials and Methods). On RNA blots, a transcript of an apparent length of about 200 nucleotides was identified in RNA from human brain (Fig. 1B) . Little or no specific labeling was evident in lanes that were loaded with RNA from human lung or kidney (Fig.  1B) or from other human organs such as breast, bladder, colon, or liver; a weak signal was, however, observed with RNA from human testis (not shown). These results indicate that the overall tissue distribution of human BC200 RNA is similar to the tissue distribution of both monkey BC200 RNA and rat BCl RNA. These RNAs have been shown to be absent from non-neural organs such as liver, spleen, kidney, skeletal muscle, and others (DeChiara and Brosius, 1987; McKinnon et al., 1987; Watson and Sutcliffe, 1987) . Using oligonucleotides specific to the 3' part of BC200 RNA in genomic DNA blot analyses, we identified two bands under high-stringency conditions ( Fig. 1 C, D) . This result indicates that maximally two BC200 RNA genes are present in the human genome.
Expression of BC200 RNA in human neural tissue
The distribution of human BC200 RNA in selected neural tissues was examined using in situ hybridization techniques. The Yj-labeled RNA probes that were generated for these experiments again corresponded to part of the unique 3' domain of BC200 RNA (see Materials and Methods). A probe complementary to this part of BC200 RNA ("antisense" probe) and a "sense" strand control probe were used in parallel. The control probe failed to produce specific labeling in any of the examined tissues (see below).
The BC200 RNA labeling pattern in the human retina is shown in Figure 3 . Labeling was restricted to the ganglion cell layer, the inner plexiform layer, and the innermost layer of the inner nuclear layer. Other layers, for example, the photoreceptor cell layer, showed little or no labeling above background, and the overall labeling pattern is thus similar to the one obtained for BCl RNA in the rat retina (Tiedge et al., 1991) . While the majority of the neurons in the ganglion cell layer seemed to be intensely labeled, few cells in the inner nuclear layer were identified by the BC200 RNA probe. The labeled neurons in the ganglion cell layer and in the innermost layer of the inner nuclear layer most likely belong to the class of ganglion cells and amacrine cells, respectively, possibly including displaced individuals of either class (Ramon y Cajal, 1892). Substantial BC200 labeling was also observed in the inner plexiform layer, the dendritic territory of ganglion cells and amacrine cells (Dowling and Boycott, 1966) . As with rat BCl RNA, this result indicates a somatodendritic location of human BC200 RNA.
The expression pattern of BC200 RNA was compared with that of the mRNA for GAP-43. GAP-43 is a neuronal protein that is associated with outgrowth, maintenance, and modification of axonal nerve terminals (for reviews, see Benowitz and Routtenberg, 1987; Skene, 1989) . In the nervous system of the rat, BCl RNA and GAP-43 mRNA have been shown to be coexpressed in many types of neurons (Tiedge et al., 1991; H. Tiedge and J. Brosius, unpublished observations) . Figure 3B shows that in the human retina, GAP-43 mRNA labeling was evident in cells of the ganglion cell layer. Only minor labeling was observed in the inner nuclear layer. Other layers, including the inner plexiform layer, showed little or no specific labeling. These results suggest that BC200 RNA and GAP-43 mRNA are expressed by the same types of neurons in the human retina; however, while BC200 RNA extends into the dendritic fields of these neurons, GAP-43 mRNA is largely confined to layers that contain neuronal somata.
Similar observations were made in the hippocampus ( Fig. 4A-E; ). BC200 RNA was detectable throughout Ammon's horn, in a slightly increasing gradient from the CA1 field to the CA3 field. Silver grains were seen overlying the layer of pyramidal cell bodies and the territory of their dendrites. Neurons of the hilar region were also strongly labeled. In dentate granule cells, the labeling signal was lower than in Ammon's horn. GAP-43 mRNA labeling paralleled that of BC200 RNA, with high signals in Ammon's horn and in the hilar region. Slightly lower labeling intensities were observed in dentate granule cells (see also Neve et al., 1988) . As in the retina, silver grains indicating the presence of GAP-43 mRNA were largely restricted to neuronal perikarya. It is interesting to note that although the labeling signals for both BC200 RNA and GAP-43 mRNA were only moderate in dentate granule cells, they seem to be higher than in equivalent cells in rat where neither BCl RNA nor GAP-43 mRNA is detectable at significant levels (Rosenthal et al., 1987; H. Tiedge and J. Brosius, unpublished observations) .
High levels of BC200 RNA were also expressed in the neocortex (Fig. 4G) . Strong labeling was seen in layers II, III, V, and VI; in other layers, the signal was weaker, but still appreciably above background. Significant labeling in layer I (which is scarcely populated by neuronal cell bodies) is again indicative of a dendritic location of BC200 RNA. Little or no specific labeling was observed in white matter areas. Although comparable observations were made in other areas of the human neocortex (not shown), it remains to be determined in a more comprehensive study whether relative labeling intensities in individual cortical layers may vary from area to area.
Discussion
We have isolated a number of overlapping cDNA clones that have been derived from human BC200 RNA. The colinearity of these clones-with the exception of homopolymeric sequences-indicates that the RNA is transcribed from only one or a few genes. This is further supported by the fact that only two bands corresponding to BC200 RNA were identified on genomic DNA blots at high stringency. Recent sequence analysis of genomic clones indeed suggests that of three BC200 RNA genes that were examined in the human genome, one is an active gene while the other two are transcriptionally silent pseudogenes (J. A. Martignetti and J. Brosius, unpublished observations). Of the two pseudogenes, only one exhibits sufficient sequence similarity with the unique regions of the true gene to be identified in genomic DNA blots at high stringency (see Fig. 1 C) .
The 5' part of BC200 RNA shares 89% sequence similarity with a stretch of 133 nucleotides comprising the left monomer of Alu-J repetitive elements in the human genome (Jurka and Milosavljevic, 1991) . It also shares sequence similarity with human SRP RNA: 86% similarity between positions 2-82 in BC200 RNA and a stretch of 79 nucleotides in the 5' part of SRP RNA, and 90% similarity between positions 87-l 15 in BC200 RNA and a stretch of 29 nucleotides in the 3' part of SRP RNA (Ullu et al., 1982 ; see also Watson and Sutcliffe, 1987 ; sequence similarity determined according to Devereux et al., 1984 ; default settings, gap weight 5.0, length weight 0.3). Sequence comparison of SRP RNAs and Alu elements from different species has led to the suggestion that SRP RNA has given rise to the family of Alu elements in mammalian genomes, conceivably in a multistep process that included retroposition events (Ullu and Tschudi, 1984) . Our sequence data indicate that the 5' part of BC200 RNA has in turn been derived from an Alu element. After retroposition, sequences downstream of the integration site may have been incorporated as the central and 3' parts of the BC200 RNA gene, with other flanking regions acting as putative upstream and/or downstream regulatory elements. Such a chain of events would support the view that retroposition is an important evolutionary factor that may play a crucial role in the generation of novel genes and gene products (Brosius, 199 1; Brosius and Gould, 1992) .
Parts of the central A-rich domain and of the 3' unique domain of BC200 RNA exhibit moderate sequence similarity with the corresponding domains in rat BC 1 RNA: the distal sequences [positions 134-187 in BC200 RNA (54 nucleotides) vs. positions 10 l-l 49 in BC 1 RNA] show 9 1% similarity (determined according to Devereux et al., 1984 ; gap weight 2.0, length weight 0.3). Except for consensus elements corresponding to boxes A and B of the split RNA polymerase III promoter (Galli et al., 1981) , the 5' part of rat BCl RNA shares little sequence similarity with BC200 RNA or with either SRP RNA or Alu elements. BCl RNA is likely to have evolved from tRNAAla (Daniels and Deininger, 1985; Lawrence et al., 1985; Sakamoto and Okada, 1985; DeChiara and Brosius, 1987) . SRP RNA is the original progenitor of BC200 RNA, via an Alu element (probably a monomeric free left arm, FLAM) as an evolutionary intermediate. Thus, the evolution of rodent BCl RNA and primate BC200 RNA has apparently proceeded via separate phylogenetic routes. Despite their different evolutionary histories, however, BCl RNA and BC200 RNA share short segments of et al. * EC200 RNA: Dendritic ExpressIon In Human Braln I w n 0 3 a limited sequence similarity (which are sufficient for cross-hybridization at low stringency). Such sequence elements may confer special functions to the RNAs, for example, the capacity to bind specific proteins or to interact with other RNAs. Human BC200 RNA is, like the rat counterpart BCl RNA, selectively expressed in the nervous system. The expression patterns of both RNAs are, to the extent that they have been investigated, strikingly similar. Thus, BC200 RNA and BCl RNA seem to be expressed by equivalent subsets of neurons in the human and rat nervous system, respectively. For example, both BCl RNA and BC200 RNA are expressed by retinal ganglion cells, whereas only negligible amounts of either RNA are found in photoreceptor cells. Similarly, in the hippocampus, both RNAs are expressed at high levels by pyramidal cells in Ammon's horn and in the hilar region. Moreover, both in the retina and in the hippocampus, the expression patterns of BC200 RNA and GAP-43 mRNA seem to overlap extensively, similar again to the situation in rat (Tiedge et al., 1991; Tiedge and Brosius, unpublished obesrvations) . The coexpression of GAP-43 mRNA and BC200 RNA in certain types of neurons is intriguing, as GAP-43 has been found earlier to be selectively expressed in associative regions of the human brain (Neve et al., 1988 ).
Significant BC200 labeling in dendrite-rich neuropil areas suggests that this RNA, again like rat BCl RNA, is located in somatodendritic domains. Thus, the similar anatomical and subcellular distribution of human BC200 RNA and rat BCl RNA is indicative of equivalent functional roles of these RNAs, in primates and rodents, respectively, in postsynaptic domains of various types of neurons. In view of their independent evolutionary histories, we would therefore classify these RNAs as functional analogs (rather than as homologs). Analogous secondary structures, although not immediately apparent from the primary sequences, may be potentially crucial for the functional roles of these RNAs. In addition, short stretches of limited sequence similarity may be vital for RNA-protein interactions that are central to the function of RNPs. The notion that the functional unit is a specific RNP has recently received support from experimental data showing that BCl RNA is indeed complexed with proteins in vivo (Kobayashi et al., 199 1, 1992; Cheng et al., 1992) . In the context of dendritic protein synthesis, such an RNP may assist in translation-related processes such as the dendritic transport and targeting of mRNAs (or, alternatively, of polyribosomes) or the arrest and reinitiation of postsynaptic translation, for example, as a function of synaptic activity. In the SRP, the protein heterodimer SRP 9/ 14 is required for translational arrest (Siegel and Walter, 1985) . A sequence element similar to the SRP RNA consensus motif that is responsible for
